Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,929 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome.
Gobert M, Treilleux I, Bendriss-Vermare N, Bachelot T, Goddard-Leon S, Arfi V, Biota C, Doffin AC, Durand I, Olive D, Perez S, Pasqual N, Faure C, Ray-Coquard I, Puisieux A, Caux C, Blay JY, Ménétrier-Caux C. Gobert M, et al. Among authors: perez s. Cancer Res. 2009 Mar 1;69(5):2000-9. doi: 10.1158/0008-5472.CAN-08-2360. Epub 2009 Feb 24. Cancer Res. 2009. PMID: 19244125
Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients.
Manuel M, Tredan O, Bachelot T, Clapisson G, Courtier A, Parmentier G, Rabeony T, Grives A, Perez S, Mouret JF, Perol D, Chabaud S, Ray-Coquard I, Labidi-Galy I, Heudel P, Pierga JY, Caux C, Blay JY, Pasqual N, Ménétrier-Caux C. Manuel M, et al. Among authors: perez s. Oncoimmunology. 2012 Jul 1;1(4):432-440. doi: 10.4161/onci.19545. Oncoimmunology. 2012. PMID: 22754761 Free PMC article.
Peripheral Blood TCR Repertoire Profiling May Facilitate Patient Stratification for Immunotherapy against Melanoma.
Hogan SA, Courtier A, Cheng PF, Jaberg-Bentele NF, Goldinger SM, Manuel M, Perez S, Plantier N, Mouret JF, Nguyen-Kim TDL, Raaijmakers MIG, Kvistborg P, Pasqual N, Haanen JBAG, Dummer R, Levesque MP. Hogan SA, et al. Among authors: perez s. Cancer Immunol Res. 2019 Jan;7(1):77-85. doi: 10.1158/2326-6066.CIR-18-0136. Epub 2018 Nov 13. Cancer Immunol Res. 2019. PMID: 30425105 Free article. Clinical Trial.
T-cell receptor diversity as a prognostic biomarker in melanoma patients.
Charles J, Mouret S, Challende I, Leccia MT, De Fraipont F, Perez S, Plantier N, Plumas J, Manuel M, Chaperot L, Aspord C. Charles J, et al. Among authors: perez s. Pigment Cell Melanoma Res. 2020 Jul;33(4):612-624. doi: 10.1111/pcmr.12866. Epub 2020 Feb 3. Pigment Cell Melanoma Res. 2020. PMID: 31971658
[Translated article] National registry and analysis of pharmaceutical interventions in critical care units: PHARMACRITIC study.
Cerezuela MM, Moreno FB, García MÁA, Fernández CB, González IA, Sacristán SC, Lugea AE, Fernández MA, Moral LD, Polo AF, García TB, Pérez SO, Chiva ED. Cerezuela MM, et al. Among authors: perez so. Farm Hosp. 2024 Nov 15:S1130-6343(24)00163-6. doi: 10.1016/j.farma.2024.10.003. Online ahead of print. Farm Hosp. 2024. PMID: 39550252 Free article. English, Spanish.
The BrEasT cancer afTER-CARE (BETTER-CARE) programme to improve breast cancer follow-up: design and feasibility study results of a cluster-randomised complex intervention trial.
Horn A, Wendel J, Franke I, Bauer A, Baumeister H, Bendig E, Brucker SY, Deutsch TM, Garatva P, Haas K, Heil L, Hügen K, Manger H, Pryss R, Rücker V, Salmen J, Szczesny A, Vogel C, Wallwiener M, Wöckel A, Heuschmann PU; BETTER-CARE Study Group. Horn A, et al. Trials. 2024 Nov 14;25(1):767. doi: 10.1186/s13063-024-08614-8. Trials. 2024. PMID: 39543763 Free PMC article.
1,929 results